107 related articles for article (PubMed ID: 38458531)
21. Internal relative potency factors based on immunotoxicity for the risk assessment of mixtures of per- and polyfluoroalkyl substances (PFAS) in human biomonitoring.
Bil W; Ehrlich V; Chen G; Vandebriel R; Zeilmaker M; Luijten M; Uhl M; Marx-Stoelting P; Halldorsson TI; Bokkers B
Environ Int; 2023 Jan; 171():107727. PubMed ID: 36628859
[TBL] [Abstract][Full Text] [Related]
22. Per- and polyfluoroalkyl substance (PFAS) exposure assessment in a community exposed to contaminated drinking water, New Hampshire, 2015.
Daly ER; Chan BP; Talbot EA; Nassif J; Bean C; Cavallo SJ; Metcalf E; Simone K; Woolf AD
Int J Hyg Environ Health; 2018 Apr; 221(3):569-577. PubMed ID: 29514764
[TBL] [Abstract][Full Text] [Related]
23. Perfluoroalkyl substances and immune cell counts in adults from the Mid-Ohio Valley (USA).
Lopez-Espinosa MJ; Carrizosa C; Luster MI; Margolick JB; Costa O; Leonardi GS; Fletcher T
Environ Int; 2021 Nov; 156():106599. PubMed ID: 33993002
[TBL] [Abstract][Full Text] [Related]
24. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
[TBL] [Abstract][Full Text] [Related]
25. Early-life exposure to perfluoroalkyl substances and serum antibody concentrations towards common childhood vaccines in 18-month-old children in the Odense Child Cohort.
Sigvaldsen A; Højsager FD; Paarup HM; Beck IH; Timmermann CAG; Boye H; Nielsen F; Halldorsson TI; Nielsen C; Möller S; Barington T; Grandjean P; Jensen TK
Environ Res; 2024 Feb; 242():117814. PubMed ID: 38042520
[TBL] [Abstract][Full Text] [Related]
26. Assessment of perfluorohexane sulfonic acid (PFHxS)-related compounds degradation potential: Computational and experimental approaches.
Zhong H; Liu W; Li N; Ma D; Zhao C; Li J; Wang Y; Jiang G
J Hazard Mater; 2022 Aug; 436():129240. PubMed ID: 35739759
[TBL] [Abstract][Full Text] [Related]
27. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
[TBL] [Abstract][Full Text] [Related]
28. Association between per and polyfluoroalkyl substances and markers of inflammation and oxidative stress.
Omoike OE; Pack RP; Mamudu HM; Liu Y; Strasser S; Zheng S; Okoro J; Wang L
Environ Res; 2021 May; 196():110361. PubMed ID: 33131681
[TBL] [Abstract][Full Text] [Related]
29. Internal Relative Potency Factors for the Risk Assessment of Mixtures of Per- and Polyfluoroalkyl Substances (PFAS) in Human Biomonitoring.
Bil W; Zeilmaker MJ; Bokkers BGH
Environ Health Perspect; 2022 Jul; 130(7):77005. PubMed ID: 35881550
[TBL] [Abstract][Full Text] [Related]
30. Immunotoxicity and allergenic potential induced by topical application of perfluorooctanoic acid (PFOA) in a murine model.
Shane HL; Baur R; Lukomska E; Weatherly L; Anderson SE
Food Chem Toxicol; 2020 Feb; 136():111114. PubMed ID: 31904477
[TBL] [Abstract][Full Text] [Related]
31. New approach for assessing human perfluoroalkyl exposure via hair.
Alves A; Jacobs G; Vanermen G; Covaci A; Voorspoels S
Talanta; 2015 Nov; 144():574-83. PubMed ID: 26452864
[TBL] [Abstract][Full Text] [Related]
32. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Premature Ovarian Insufficiency in Chinese Women.
Zhang S; Tan R; Pan R; Xiong J; Tian Y; Wu J; Chen L
J Clin Endocrinol Metab; 2018 Jul; 103(7):2543-2551. PubMed ID: 29986037
[TBL] [Abstract][Full Text] [Related]
33. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
[TBL] [Abstract][Full Text] [Related]
34. Serum concentrations of per-/polyfluoroalkyl substances and risk of type 2 diabetes: A case-control study.
Duan Y; Sun H; Yao Y; Li Y; Meng Y; Lu Y; Han L; Chen L
Sci Total Environ; 2021 Sep; 787():147476. PubMed ID: 33992947
[TBL] [Abstract][Full Text] [Related]
35. Association among serum per- and polyfluoroalkyl substances, lipid profile and metabolic syndrome in Czech adults, HBM-EHES survey 2019.
Puklová V; Čapková N; Fialová A; Vavrouš A; Žejglicová K; Černá M
Cent Eur J Public Health; 2023 Dec; 31(4):227-234. PubMed ID: 38309699
[TBL] [Abstract][Full Text] [Related]
36. Distribution of per- and polyfluoroalkyl substances in blood, serum, and urine of patients with liver cancer and associations with liver function biomarkers.
Dai C; Peng L; Li Y; Li Z; Chen D; Wang F; Lin N
J Environ Sci (China); 2024 May; 139():418-427. PubMed ID: 38105065
[TBL] [Abstract][Full Text] [Related]
37. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
[TBL] [Abstract][Full Text] [Related]
38. In ovo effects of perfluorohexane sulfonate and perfluorohexanoate on pipping success, development, mRNA expression, and thyroid hormone levels in chicken embryos.
Cassone CG; Vongphachan V; Chiu S; Williams KL; Letcher RJ; Pelletier E; Crump D; Kennedy SW
Toxicol Sci; 2012 May; 127(1):216-24. PubMed ID: 22302310
[TBL] [Abstract][Full Text] [Related]
39. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
[TBL] [Abstract][Full Text] [Related]
40. Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls.
Maisonet M; Terrell ML; McGeehin MA; Christensen KY; Holmes A; Calafat AM; Marcus M
Environ Health Perspect; 2012 Oct; 120(10):1432-7. PubMed ID: 22935244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
